METHOD FOR TREATING RELAPSING BRONCHITIS IN CHILDREN

FIELD: medicine, pulmonology, pediatrics. ^ SUBSTANCE: the present innovation deals with treating relapsing nonobstructive bronchitis in children. Due to inhalations it is necessary to introduce Aldecin into bronchi at the dosage of 200-300 mcg/d. The dosage should be decreased by 50 mcg weekly. The...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KARPOVA IRINA ANATOL'EVNA, L'VOVA IRINA IOSIFOVNA, VESELOVSKIJ ALEKSEJ EVGEN'EVICH, ILJUSHIN DENIS JUR'EVICH
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine, pulmonology, pediatrics. ^ SUBSTANCE: the present innovation deals with treating relapsing nonobstructive bronchitis in children. Due to inhalations it is necessary to introduce Aldecin into bronchi at the dosage of 200-300 mcg/d. The dosage should be decreased by 50 mcg weekly. The period for dosage decrease corresponds to about 3-5 wk. Total duration of therapy course corresponds to about 2-3 mo. The innovation provides efficient removal of bronchial hyperactivity and allergic predisposition of respiratory tract and leads to no relapses during prolonged period of time and proves the necessity to apply glucocorticoids for this category of patients. ^ EFFECT: higher efficiency of therapy. ^ 3 ex